82 FR 52927 - Agency Information Collection Activities; Proposed Collection; Comment Request; Infant Formula Requirements
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration Federal Register Volume 82, Issue 219 (November 15, 2017)
Food and Drug Administration
Federal Register Volume 82, Issue 219 (November 15, 2017)
| Page Range | 52927-52933 | |
| FR Document | 2017-24688 |
[Federal Register Volume 82, Number 219 (Wednesday, November 15, 2017)] [Notices] [Pages 52927-52933] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-24688] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2013-N-0545] Agency Information Collection Activities; Proposed Collection; Comment Request; Infant Formula Requirements AGENCY: Food and Drug Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA or we) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice invites comments on the information collection provisions of our infant formula regulations, including infant formula labeling, quality control procedures, notification requirements, and recordkeeping. The notice also invites comment on a pilot electronic form that allows manufacturers of infant formula to submit reports and notifications in a standardized format. DATES: Submit either electronic or written comments on the collection of information by January 16, 2018. ADDRESSES: You may submit comments as follows. Please note that late, untimely filed comments will not be considered. Electronic comments must be submitted on or before January 16, 2018. The https://www.regulations.gov electronic filing system will accept comments until midnight Eastern Time at the end of January 16, 2018. Comments received by mail/hand delivery/courier (for written/paper submissions) will be considered timely if they are postmarked or the delivery service acceptance receipt is on or before that date. Electronic Submissions Submit electronic comments in the following way:Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https://www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else's Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https://www.regulations.gov. If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see ``Written/Paper Submissions'' and ``Instructions''). Written/Paper Submissions Submit written/paper submissions as follows: Mail/Hand delivery/Courier (for written/paper submissions): Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. For written/paper comments submitted to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in ``Instructions.'' Instructions: All submissions received must include the Docket No. FDA-2013-N-0545 for ``Agency Information Collection Activities; Proposed Collection; Comment Request; Infant Formula Requirements.'' Received comments, those filed in a timely manner (see ADDRESSES), will be placed in the docket and, except for those submitted as ``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through Friday. Confidential Submissions--To submit a comment with confidential information that you do not wish to be made publicly available, submit your comments only as a written/paper submission. You should submit two copies total. One copy will include the information you claim to be confidential with a heading or cover note that states ``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will review this copy, including the claimed confidential information, in its consideration of comments. The second copy, which will have the claimed confidential information redacted/blacked out, will be available for public viewing and posted on [[Page 52928]] https://www.regulations.gov. Submit both copies to the Dockets Management Staff. If you do not wish your name and contact information to be made publicly available, you can provide this information on the cover sheet and not in the body of your comments and you must identify this information as ``confidential.'' Any information marked as ``confidential'' will not be disclosed except in accordance with 21 CFR 10.20 and other applicable disclosure law. For more information about FDA's posting of comments to public dockets, see 80 FR 56469, September 18, 2015, or access the information at: https://www.thefederalregister.org/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf. Docket: For access to the docket to read background documents or the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in the heading of this document, into the ``Search'' box and follow the prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, [email protected]. SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal Agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. ``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes Agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires Federal Agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, FDA is publishing notice of the proposed collection of information set forth in this document. With respect to the following collection of information, we invite comments on these topics: (1) Whether the proposed collection of information is necessary for the proper performance of FDA's functions, including whether the information will have practical utility; (2) the accuracy of FDA's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques, when appropriate, and other forms of information technology. Infant Formula Requirements--21 CFR parts 106 and 107 OMB Control Number 0910-0256--Extension Statutory requirements for infant formula under the Federal Food, Drug, and Cosmetic Act (the FD&C Act) are intended to protect the health of infants and include a number of reporting and recordkeeping requirements. Among other things, section 412 of the FD&C Act (21 U.S.C. 350a) requires manufacturers of infant formula to establish and adhere to quality control procedures, notify us when a batch of infant formula that has left the manufacturers' control may be adulterated or misbranded, and keep records of distribution. We have issued regulations to implement the FD&C Act's requirements for infant formula in parts 106 and 107 (21 CFR parts 106 and 107). We also regulate the labeling of infant formula under the authority of section 403 of the FD&C Act (21 U.S.C. 343). Under our labeling regulations for infant formula in part 107, the label of an infant formula must include nutrient information and directions for use. The purpose of these labeling requirements is to ensure that consumers have the information they need to prepare and use infant formula appropriately. We have developed an electronic form (Form FDA 3978) that infant formula manufacturers will be able to use to electronically submit reports and notifications in a standardized format to FDA. Manufacturers that prefer to submit paper submissions in a format of their own choosing will still have the option to do so, however. Form FDA 3978 prompts a respondent to include reports and notifications in a standard electronic format and helps the respondent organize their submission to include only the information needed for our review. Draft screenshots of Form FDA 3978 and instructions are available for comment at http://www.fda.gov/Food/GuidanceRegulation/FoodFacilityRegistration/InfantFormula/default.htm. Description of Respondents: Respondents to this information collection are manufacturers of infant formula. We estimate the burden of this collection of information as follows: Table 1--Estimated Annual Reporting Burden \1\ ---------------------------------------------------------------------------------------------------------------- Number of Row No. FD&C Act or 21 Number of responses per Total annual Average burden Total hours CFR section respondents respondent responses per response ---------------------------------------------------------------------------------------------------------------- 1.......... Reports; Section 5 13 65 10............... 650 412(d) of the FD&C Act. 2.......... Notifications; 1 1 1 4................ 4 Sec. 106.120(b). 3.......... Reports for 3 2 6 4................ 24 Exempt Infant Formula; Sec. 107.50(b)(3) and (4). 4.......... Notifications 1 1 1 4................ 4 for Exempt Infant Formula;Sec. 107.50(e)(2). 5.......... Requirements for 4 9 36 20............... 720 Quality Factors Growth Monitoring Study Exemption; Sec. 106.96(c). 6.......... Requirements for 1 34 34 12............... 408 Quality Factors--PER Exemption; Sec. 106.96(g). 7.......... New Infant 4 9 36 0.50 (30 minutes) 18 Formula Registration; Sec. 106.110. 8.......... New Infant 4 9 36 10............... 360 Formula Submission; Sec. 106.120. ---------------------------------------------------------------------------------- Total........ .............. .............. .............. ................. 2,188 ---------------------------------------------------------------------------------------------------------------- \1\ There are no capital costs or operating and maintenance costs associated with this collection of information. [[Page 52929]] In compiling these estimates, we consulted our records of the number of infant formula submissions received in the past. All infant formula submissions may be provided to us in electronic format. The hours per response reporting estimates are based on our experience with similar programs and information received from industry. We estimate that we will receive 13 reports from 5 manufacturers annually under section 412(d) of the FD&C Act, for a total annual response of 65 reports. Each report is estimated to take 10 hours per response for a total of 650 hours. We also estimate that we receive one notification under Sec. 106.120(b). The notification is expected to take 4 hours per response, for a total of 4 hours. For exempt infant formula, we estimate that we receive two reports from three manufacturers annually under Sec. 107.50(b)(3) and (4), for a total annual response of six reports. Each report is estimated to take 4 hours per response for a total of 24 hours. We also estimate that we receive one notification annually under Sec. 107.50(e)(2) and that the notification takes 4 hours to prepare. We estimate that 4 firms submit 36 exemptions annually and that each exemption will take 20 hours to assemble. Therefore, we calculate 36 exemptions x 20 hours = 720 hours as the estimated burden for Sec. 106.96(c), as presented in row 5 of table 1. We estimate that the infant formula industry annually submits 35 Protein Efficiency Ratio (PER) submissions. For the submission of the PER exemption, we estimate that the infant formula industry submits 34 exemptions per year and that each exemption takes supporting staff 12 hours to prepare. Therefore, we calculate 34 exemptions x 12 hours per exemption = 408 hours to fulfill the requirements of Sec. 106.96(g), as shown in row 6 of table 1. We estimate that four firms each use one senior scientist or regulatory affairs professional who needs 30 minutes to gather and record the required information for an infant formula registration pursuant to Sec. 106.110. We estimate that the industry annually registers 35 new infant formulas, or an average of 9 registrations per firm. Therefore, we calculate the annual burden as 36 registrations x 0.5 hour per registration = 17.5 (rounded to 18) hours, as shown in row 7 of table 1. We estimate that four firms each use one senior scientist or regulatory affairs professional who needs 10 hours to gather and record information needed for infant formula submissions pursuant to Sec. 106.120. This estimate includes the time needed to gather and record the information the manufacturer uses to request an exemption under Sec. 106.91(b)(1)(ii), which provides that the manufacturer includes the scientific evidence that the manufacturer is relying on to demonstrate that the stability of the new infant formula will likely not differ from the stability of formula with similar composition, processing, and packaging for which there are extensive stability data. We estimate that 4 firms make submissions for 36 new infant formulas, or an average of 9 submissions per firm. Therefore, to comply with Sec. 106.120, we calculate the annual burden as 36 submissions x 10 hours per submission = 360 hours, as shown in row 8 of table 1. Thus, the total annual reporting burden is 2,188 hours. Table 2--Estimated Annual Recordkeeping Burden \1\ \2\ ---------------------------------------------------------------------------------------------------------------- Number of Average burden Row No. Activity; 21 CFR Number of records per Total annual per Total hours section recordkeepers recordkeeper records recordkeeping ---------------------------------------------------------------------------------------------------------------- 1........... Controls to 21 1 21 1.5 (90 minutes) 32 prevent adulteration caused by facilities--tes ting for radiological contaminants \3\; Sec. 106.20(f)(3). 2........... Controls to 21 1 21 0.08 (5 minutes) 2 prevent adulteration caused by facilities--rec ordkeeping of testing for radiological contaminants\2\ ; Sec. Sec. 106.20(f)(4) and 106.100(f)(1). 3........... Controls to 5 52 260 0.08 (5 minutes) 21 prevent adulteration caused by facilities--tes ting for bacteriological contaminants Sec. 106.20(f)(3). 4........... Controls to 5 52 260 0.08 (5 minutes) 21 prevent adulteration caused by facilities--rec ordkeeping of testing for bacteriological contaminants Sec. Sec. 106.20(f)(4) and 106.100(f). 5........... Controls to 5 52 260 0.22 (13 57 prevent minutes). adulteration by equipment or utensils; Sec. Sec. 106.30(d) and 106.100(f)(2). 6........... Controls to 5 52 260 0.22 (13 57 prevent minutes). adulteration by equipment or utensils; Sec. Sec. 106.30(e)(3)(ii i) and 106.100(f)(3). 7........... Controls to 5 52 260 0.20 (12 52 prevent minutes). adulteration by equipment or utensils; Sec. Sec. 106.30(f) and 106.100(f)(4). [[Page 52930]] 8........... Controls to 5 1 5 520............. 2,600 prevent adulteration due to automatic (mechanical or electronic) equipment; Sec. Sec. 106.35(c) and 106.100(f)(5). 9........... Controls to 5 2 10 640............. 6,400 prevent adulteration due to automatic (mechanical or electronic) equipment Sec. Sec. 106.35(c) and 106.100(f)(5). 10.......... Controls to 5 52 260 0.17 (10 44 prevent minutes). adulteration caused by ingredients, containers, and closures; Sec. Sec. 106.40(d) and 106.100(f)(6). 11.......... Controls to 5 52 260 0.23 (14 60 prevent minutes). adulteration during manufacturing; Sec. Sec. 106.50(a)(1) and 106.100(e). 12.......... Controls to 5 52 260 0.25 (15 65 prevent minutes). adulteration from microorganisms; Sec. Sec. 106.55(d) and 106.100(e)(5)(i i) and (f)(7). 13.......... Controls to 1 12 12 0.25 (15 3 prevent minutes). adulteration during packaging and labeling of infant formula; Sec. 106.60(c). 14.......... General quality 4 1 4 2............... 8 control--testin g; Sec. 106.91(b)(1), (2), and (3). 15.......... General quality 4 52 208 0.15 (9 minutes) 31 control; Sec. Sec. 106.91(b)(1) and(d), and 106.100(e)(5)(i ). 16.......... General quality 4 52 208 0.15 (9 minutes) 31 control; Sec. Sec. 106.91(b)(2) and (d), and 106.100(e)(5)(i ). 17.......... General quality 4 52 208 0.15 (9 minutes) 31 control; Sec. Sec. 106.91(b)(3) and (d), and 106.100(e)(5)(i ). 18.......... Audit plans and 5 1 5 8............... 40 procedures; ongoing review and updating of audits; Sec. 106.94. 19.......... Audit plans and 5 52 260 4............... 1,040 procedures -- regular audits; Sec. 106.94. 20.......... Requirements for 1 1 1 16.............. 16 quality factors for infant formulas--writt en study report; Sec. Sec. 106.96(b) and (d), 106.100(p)(1) and (q)(1), and 106.121. 21.......... Requirements for 112 6 672 0.50 (30 336 quality factors minutes). for infant formulas--anthr opometric data; Sec. Sec. 106.96(b)(2) and (d), and 106.100(p)(1). 22.......... Requirements for 112 6 672 0.25 (15 168 quality factors minutes). for infant formulas--formu la intake Sec. Sec. 106.96(b)(3) and (d), and 106.100(p)(1). 23.......... Requirements for 112 6 672 0.08 (5 minutes) 54 quality factors for infant formulas--data plotting; Sec. Sec. 106.96(b)(4) and (d), and 106.100(p)(1). 24.......... Requirements for 112 6 672 0.08 (5 minutes) 54 quality factors for infant formulas--data comparison; Sec. Sec. 106.96(b)(5) and (d), and 106.100(p)(1). [[Page 52931]] 25.......... Requirements for 1 1 1 8............... 8 quality factors--per data collection; Sec. 106.96(f). 26.......... Requirements for 1 1 1 1............... 1 quality factors--per written report; Sec. 106.96(f). 27.......... Records; Sec. 5 10 50 400............. 20,000 106.100. 28.......... Records for 3 10 30 300............. 9,000 Exempt Infant Formula; Sec. 107.50(c)(3). --------------------------------------------------------------------------------- Total........ .............. .............. .............. ................ 40,232 ---------------------------------------------------------------------------------------------------------------- \1\ There are no capital costs or operating and maintenance costs associated with this collection of information. \2\ Where necessary, numbers have been rounded to the nearest whole number. \3\ This testing only occurs every 4 years. We estimate that 21 infant formula plants will test at least every 4 years for radiological contaminants. In addition, we estimate that collecting water for all testing in Sec. 106.20(f)(3) takes between 1 and 2 hours. We estimate that water collection takes an average of 1.5 hours and that water collection occurs separately for each type of testing. We estimate that performing the test will take 1.5 hours per test, every 4 years. Therefore, 1.5 hours per plant x 21 plants = 31.5 (rounded to 32) total hours, every 4 years, as seen in row 1 of table 2. Furthermore, Sec. Sec. 106.20(f)(4) and 106.100(f)(1) require firms to make and retain records of the frequency and results of water testing. For the 21 plants that are estimated not to currently test for radiological contaminants, this burden is estimated to be 5 minutes per record every 4 years. Therefore, 0.08 hour per record x 21 plants = 1.68 (rounded to 2) hours, every 4 years for the maintenance of records of radiological testing, as seen on row 2 of table 2. We estimate that five infant formula plants will test weekly for bacteriological contaminants. We estimate that performing the test will take 5 minutes per test once a week. Annually, this burden is 0.08 hours x 52 weeks = 4.16 hours per year, per plant, and 4.16 hours per plant x 5 plants = 20.8 (rounded to 21) total annual hours, as seen on row 3 of table 2. Furthermore, for the five plants that are estimated to not currently test weekly for bacteriological contaminants, this burden is estimated to be 5 minutes per record, every week. Therefore, 0.08 hour per record x 52 weeks = 4.16 hours per plant for the maintenance of records of bacteriological testing. Accordingly, 4.16 hours x 5 plants = 20.8 (rounded to 21) annual hours, as seen on row 4 of table 2. Sections 106.30(d) and 106.100(f)(2) require that records of calibrating certain instruments be made and retained. We estimate that one senior validation engineer for each of the five plants will need to spend about 13 minutes per week to satisfy the ongoing calibration recordkeeping requirements. Therefore, 5 recordkeepers x 52 weeks = 260 records; 260 records x 0.22 hour per record = 57 hours as the annual burden, as presented in row 5 of table 2. Sections 106.30(e)(3)(iii) and 106.100(f)(3)) require the recordkeeping of the temperatures of each cold storage compartment. We estimate that five plants will each require one senior validation engineer about 13 minutes per week of recordkeeping. Therefore, 5 recordkeepers x 52 weeks = 260 records; 260 records x 0.22 hours per record = 57 hours as the annual burden, as presented in row 6 of table 2. Sections 106.30(f) and 106.100(f)(4) require the recordkeeping of ongoing sanitation efforts. We estimate that five plants will each require one senior validation engineer about 12 minutes per week of recordkeeping. Therefore, 5 recordkeepers x 52 weeks = 260 records; 260 records x 0.20 hours per record = 52 hours as the annual burden, as presented in row 7 of table 2. For Sec. Sec. 106.35(c) and 106.100(f)(5), we estimate that one senior validation engineer per plant needs 10 hours per week of recordkeeping, with the annual burden for this provision being 520 hours per plant x 5 plants = 2,600 annual hours, as shown in row 8 of table 2. In addition, an infant formula manufacturer revalidates its systems when it makes changes to automatic equipment. We estimate that such changes occur twice a year, and that on each of the two occasions, a team of four senior validation engineers per plant needs to work full time for 4 weeks (4 weeks x 40 hours per week = 160 work hours per person) to provide revalidation of the plant's automated systems sufficient to comply with this section. The annual burden for four senior validation engineers each working 160 hours twice a year is 1,280 hours ((160 hours x 2 revalidations) x 4 engineers = 1,280 total work hours) per plant. Therefore, 640 hours x 5 plants x 2 times per year = 6,400 hours as the annual burden, as shown on row 9 of table 2. Sections 106.40(d) and 106.100(f)(6) require written specifications for ingredients, containers, and closures. We estimate that one senior validation engineer per plant needs about 10 minutes a week to fulfill the recordkeeping requirements. Therefore, 5 recordkeepers x 52 weeks = 260 records and 260 records x 0.17 hour = 44 hours as the annual burden, as shown in row 10 of table 2. We estimate that five plants will change a master manufacturing order and that one senior validation engineer for each of the five plants spends about 14 minutes per week on recordkeeping pertaining to the master manufacturing order, as required by Sec. Sec. 106.50(a)(1) and 106.100(e). Thus, 5 recordkeepers x 52 weeks = 260 records; 260 records x 0.23 hour = 60 hours as the annual burden, as shown in row 11 of table 2. Sections 106.55(d), 106.100(e)(5)(ii), and 106.100(f)(7)) require recordkeeping of the testing of infant formula for microorganisms. We estimate that five plants each need one senior validation engineer to spend 15 minutes per week on recordkeeping pertaining to microbiological testing. Thus, 5 recordkeepers x 52 weeks = 260 records; 260 records x 0.25 hour per record = 65 hours as the annual burden, as shown in row 12 of table 2. [[Page 52932]] Section 106.60 establishes requirements for the recordkeeping and labeling of mixed-lot packages of infant formula. Section 106.60(c) requires infant formula diverters to label infant formula packaging (such as packing cases) to facilitate product tracing and to keep specific records of the distribution of these mixed lot cases. We estimate that one worker needs 15 minutes, once a month (0.25 x 12 months) to accomplish this, for an annual burden of 3 hours, as shown in row 13 of table 2. Sections 106.91(b)(1), (2), and (3) provide ongoing stability testing requirements. We estimate that the stability testing requirements has a burden of 2 hours per plant. Therefore, 2 hours x 4 plants = 8 hours as the annual burden to fulfill the testing requirements, as shown in row 14 of table 2. Sections 106.91(d) and 106.100(e)(5)(i) provide for recordkeeping of tests required under Sec. 106.91(b)(1), (2), and (3). We estimate that one senior validation engineer per plant will spend about 9 minutes per week of recordkeeping to be in compliance. Thus, 4 recordkeepers x 52 weeks = 208 records; 208 records x 0.15 hour per record = 31.2 (rounded to 31) hours for the annual burden, as shown in rows 15, 16, and 17 of table 2. We estimate that the ongoing review and updating of audit plans requires a senior validation engineer 8 hours per year, per plant. Therefore, 8 hours x 5 plants = 40 hours for the annual burden, as shown in row 18 of table 2. We estimate that a manufacturer chooses to audit once per week. We estimate each weekly audit requires a senior validation engineer 4 hours, or 52 weeks x 4 hours = 208 hours per plant. Therefore, burden for updating audit plans is calculated as 208 hours x 5 plants = 1,040 hours for the annual burden, as shown in row 19 of table 2. We estimate that, as a result of the regulations, the industry as a whole performs one additional growth study per year, in accordance with Sec. 106.96. The regulations require that several pieces of data be collected and maintained for each infant in the growth study. We estimate that the data collection associated with the growth study is assembled into a written report and kept as a record in compliance with Sec. Sec. 106.96(d) and 106.100(p)(1). Thus, we estimate that one additional growth study report is generated, and that this report requires one senior scientist to work 16 hours to compile the data into a study report. Therefore, one growth study report x 16 hours = 16 hours for the annual burden for compliance with Sec. Sec. 106.96(b) and (d), 106.100(p)(1) and (q)(1), and 106.121 as shown in row 20 of table 2. A study conducted according to the requirements of Sec. 106.96(b)(2) must include the collection of anthropometric measurements of physical growth and information on formula intake, and Sec. Sec. 106.96(d) and 106.100(p)(1) require that the anthropometric measurements be made six times during the growth study. We estimate that in a growth study of 112 infants, 2 nurses or other health professionals with similar experience need 15 minutes per infant at each of the required 6 times to collect and record the required anthropometric measurements. Therefore, 2 nurses x 0.25 hours = 0.50 hour per infant, per visit, and 0.50 hour x 6 visits = 3 hours per infant. For 112 infants in the study, 3 hours x 112 infants = 336 hours for the annual burden, as shown in row 21 of table 2. In addition, we estimate that one nurse needs 15 minutes per infant to collect and record the formula intake information. That is, 0.25 hour x 6 visits = 1.5 hour per infant, and 1.5 hour per infant x 112 infants = 168 hours for the annual burden, as shown in row 22 of table 2. Section 106.96(b)(4) requires plotting each infant's anthropometric measurements on the Centers for Disease Control-recommended World Health Organization Child Growth Standards. We estimate that it takes 5 minutes per infant to record the anthropometric data on the growth chart at each study visit. Therefore, 112 infants x 6 data plots = 672 data plots, and 672 data plots x 0.08 hour per comparison = 53.75 hours (rounded to 54) for the annual burden, as shown in row 23 of table 2. Section 106.96(b)(5) requires that data on formula intake by the test group be compared to the intake of a concurrent control group. We estimate that one nurse or other health care professional with similar experience needs 5 minutes per infant for each of the six times anthropometric data are collected. Therefore, 6 comparisons of data x 112 infants = 672 data comparisons and 672 data comparisons x 0.08 hour per comparison = 53.75 hours (rounded to 54) for the annual burden, as shown in row 24 of table 2. Section 106.96(f) provides that a manufacturer meets the quality factor of sufficient biological quality of the protein by establishing the biological quality of the protein in the infant formula when fed as the sole source of nutrition using an appropriate modification of the PER rat bioassay. Under Sec. 106.96(g)(1), a manufacturer of infant formula may be exempt from this requirement if the manufacturer requests an exemption and provides assurances, as required under Sec. 106.121, that changes made by the manufacturer to an existing infant formula are limited to changing the type of packaging. A manufacturer may also be exempt from this requirement under Sec. 106.100(g)(2), if the manufacturer requests an exemption and provides assurances, as required under Sec. 106.121, that demonstrate to FDA's satisfaction that the change to an existing formula does not affect the bioavailability of the protein. Finally, a manufacturer of infant formula may be exempt from this requirement under Sec. 106.96(g)(3) if the manufacturer requests an exemption and provides assurances, as required under Sec. 106.121(i), that demonstrate that an alternative method to the PER that is based on sound scientific principles is available to show that the formula supports the quality factor for the biological quality of the protein. We estimate that the infant formula industry submits a total of 35 PER submissions: 34 exemption requests and the results of 1 PER study. A PER study conducted according to the Association of Analytical Communities Official Method 960.48 is 28 days in duration. We estimate that there will be 10 rats in the control and test groups (20 rats total) and that food consumption and body weight will be measured at day 0 and at 7-day intervals during the 28-day study period (a total of 5 records per rat). We further estimate that measuring and recording food consumption and body weight will take 5 minutes per rat. Therefore, 20 rats x 5 records = 100 records; 100 records x 0.08 hour minutes per record = 8 hours to fulfill the requirements of Sec. 106.96(f). Further, we estimate that a report based on the PER study will be generated and that this study report will take a senior scientist 1 hour to generate. Therefore, a total of 9 hours will be required to fulfill the requirements for Sec. 106.96(f): 8 hours for the PER study and data collection, and 1 hour for the development of a report based on the PER study, as shown in rows 25 and 26 of table 2. We estimate that five firms will expend approximately 20,000 hours per year to fully satisfy the recordkeeping requirements in Sec. 106.100 and that three firms will expend approximately 9,000 hours per year to fully satisfy the recordkeeping requirements in Sec. 107.50(c)(3). Thus, the total recordkeeping burden is 40,232 hours. [[Page 52933]] Table 3--Estimated Annual Third-Party Disclosure Burden \1\ ---------------------------------------------------------------------------------------------------------------- Number of Number of disclosures Total annual Average burden 21 CFR section respondents per disclosures per disclosure Total hours respondent ---------------------------------------------------------------------------------------------------------------- Nutrient labeling; 21 CFR 5 13 65 8 520 107.10(a) and 107.20........... ---------------------------------------------------------------------------------------------------------------- \1\ There are no capital costs or operating and maintenance costs associated with this collection of information. We estimate compliance with our labeling requirements in Sec. Sec. 107.10(a) and 107.20 requires 520 hours annually by five manufacturers. Dated: November 8, 2017. Anna K. Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis. [FR Doc. 2017-24688 Filed 11-14-17; 8:45 am] BILLING CODE 4164-01-P
![Federal Register / Vol. 82, No. 219 / Wednesday, November 15, 2017 / Notices 52927
FEDERAL RESERVE SYSTEM DEPARTMENT OF HEALTH AND solely responsible for ensuring that your
HUMAN SERVICES comment does not include any
Formations of, Acquisitions by, and confidential information that you or a
Mergers of Bank Holding Companies Food and Drug Administration third party may not wish to be posted,
[Docket No. FDA–2013–N–0545] such as medical information, your or
The companies listed in this notice anyone else’s Social Security number, or
have applied to the Board for approval, Agency Information Collection confidential business information, such
pursuant to the Bank Holding Company Activities; Proposed Collection; as a manufacturing process. Please note
Act of 1956 (12 U.S.C. 1841 et seq.) Comment Request; Infant Formula that if you include your name, contact
(BHC Act), Regulation Y (12 CFR part Requirements information, or other information that
225), and all other applicable statutes identifies you in the body of your
AGENCY: Food and Drug Administration, comments, that information will be
and regulations to become a bank HHS.
holding company and/or to acquire the posted on https://www.regulations.gov.
ACTION: Notice. • If you want to submit a comment
assets or the ownership of, control of, or
with confidential information that you
the power to vote shares of a bank or SUMMARY: The Food and Drug
do not wish to be made available to the
bank holding company and all of the Administration (FDA or we) is
public, submit the comment as a
banks and nonbanking companies announcing an opportunity for public
written/paper submission and in the
owned by the bank holding company, comment on the proposed collection of
manner detailed (see ‘‘Written/Paper
including the companies listed below. certain information by the Agency.
Submissions’’ and ‘‘Instructions’’).
Under the Paperwork Reduction Act of
The applications listed below, as well Written/Paper Submissions
1995 (PRA), Federal Agencies are
as other related filings required by the required to publish notice in the
Board, are available for immediate Submit written/paper submissions as
Federal Register concerning each follows:
inspection at the Federal Reserve Bank proposed collection of information, • Mail/Hand delivery/Courier (for
indicated. The applications will also be including each proposed extension of an written/paper submissions): Dockets
available for inspection at the offices of existing collection of information, and Management Staff (HFA–305), Food and
the Board of Governors. Interested to allow 60 days for public comment in Drug Administration, 5630 Fishers
persons may express their views in response to the notice. This notice Lane, Rm. 1061, Rockville, MD 20852.
writing on the standards enumerated in invites comments on the information • For written/paper comments
the BHC Act (12 U.S.C. 1842(c)). If the collection provisions of our infant submitted to the Dockets Management
proposal also involves the acquisition of formula regulations, including infant Staff, FDA will post your comment, as
a nonbanking company, the review also formula labeling, quality control well as any attachments, except for
includes whether the acquisition of the procedures, notification requirements, information submitted, marked and
nonbanking company complies with the and recordkeeping. The notice also identified, as confidential, if submitted
standards in section 4 of the BHC Act invites comment on a pilot electronic as detailed in ‘‘Instructions.’’
(12 U.S.C. 1843). Unless otherwise form that allows manufacturers of infant Instructions: All submissions received
noted, nonbanking activities will be formula to submit reports and must include the Docket No. FDA–
conducted throughout the United States. notifications in a standardized format. 2013–N–0545 for ‘‘Agency Information
DATES: Submit either electronic or Collection Activities; Proposed
Unless otherwise noted, comments
written comments on the collection of Collection; Comment Request; Infant
regarding each of these applications
information by January 16, 2018. Formula Requirements.’’ Received
must be received at the Reserve Bank comments, those filed in a timely
ADDRESSES: You may submit comments
indicated or the offices of the Board of manner (see ADDRESSES), will be placed
as follows. Please note that late,
Governors not later than December 11, in the docket and, except for those
untimely filed comments will not be
2017. submitted as ‘‘Confidential
considered. Electronic comments must
A. Federal Reserve Bank of San be submitted on or before January 16, Submissions,’’ publicly viewable at
Francisco (Gerald C. Tsai, Director, 2018. The https://www.regulations.gov https://www.regulations.gov or at the
Applications and Enforcement) 101 electronic filing system will accept Dockets Management Staff between 9
Market Street, San Francisco, California comments until midnight Eastern Time a.m. and 4 p.m., Monday through
94105–1579: at the end of January 16, 2018. Friday.
Comments received by mail/hand • Confidential Submissions—To
1. CBC Bancorp; to become a bank submit a comment with confidential
holding company by acquiring 98.3 delivery/courier (for written/paper
submissions) will be considered timely information that you do not wish to be
percent of the voting shares of NCAL made publicly available, submit your
Bancorp, and thereby indirectly acquire if they are postmarked or the delivery
service acceptance receipt is on or comments only as a written/paper
Commercial Bank of California, all of submission. You should submit two
before that date.
Irvine, California. copies total. One copy will include the
Board of Governors of the Federal Reserve
Electronic Submissions information you claim to be confidential
System, November 8, 2017. Submit electronic comments in the with a heading or cover note that states
Yao-Chin Chao, following way: ‘‘THIS DOCUMENT CONTAINS
• Federal eRulemaking Portal: CONFIDENTIAL INFORMATION.’’ The
sradovich on DSK3GMQ082PROD with NOTICES
Assistant Secretary of the Board.
https://www.regulations.gov. Follow the Agency will review this copy, including
[FR Doc. 2017–24653 Filed 11–14–17; 8:45 am]
instructions for submitting comments. the claimed confidential information, in
BILLING CODE P Comments submitted electronically, its consideration of comments. The
including attachments, to https:// second copy, which will have the
www.regulations.gov will be posted to claimed confidential information
the docket unchanged. Because your redacted/blacked out, will be available
comment will be made public, you are for public viewing and posted on
VerDate Sep<11>2014 19:58 Nov 14, 2017 Jkt 244001 PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 E:\FR\FM\15NON1.SGM 15NON1](https://thefederalregister.org/doc/82_FR_53146/page/1.svg)
![Federal Register / Vol. 82, No. 219 / Wednesday, November 15, 2017 / Notices 52933
TABLE 3—ESTIMATED ANNUAL THIRD-PARTY DISCLOSURE BURDEN 1
Number of Average
Number of disclosures Total annual
21 CFR section burden per Total hours
respondents per disclosures disclosure
respondent
Nutrient labeling; 21 CFR 107.10(a) and 107.20 ................ 5 13 65 8 520
1 There are no capital costs or operating and maintenance costs associated with this collection of information.
We estimate compliance with our I. Purpose Registration may be completed online at
labeling requirements in §§ 107.10(a) The Physician-Focused Payment www.regonline.com/
and 107.20 requires 520 hours annually Model Technical Advisory Committee PTACMeetingsRegistration.
by five manufacturers. (‘‘the Committee’’) is required by the The following information is
Dated: November 8, 2017. Medicare Access and CHIP submitted when registering:
Anna K. Abram, Reauthorization Act of 2015, 42 U.S.C.
1395ee. This Committee is also Name:
Deputy Commissioner for Policy, Planning,
Legislation, and Analysis. governed by provisions of the Federal Company/organization name:
[FR Doc. 2017–24688 Filed 11–14–17; 8:45 am] Advisory Committee Act, as amended (5 Postal address:
BILLING CODE 4164–01–P U.S.C. App.), which sets forth standards
for the formation and use of federal Email address:
advisory committees. In accordance Persons wishing to attend this
DEPARTMENT OF HEALTH AND with its statutory mandate, the meeting must register by following the
HUMAN SERVICES Committee is to review physician- instructions in the ‘‘Meeting
focused payment model proposals and Registration’’ section of this notice. A
Meetings Announcement for the prepare recommendations regarding confirmation email will be sent to
Physician-Focused Payment Model whether such models meet criteria that registrants shortly after completing the
Technical Advisory Committee were established through rulemaking by registration process.
Required by the Medicare Access and the Secretary of Health and Human
CHIP Reauthorization Act of 2015 Services (the Secretary). The Committee IV. Special Accommodations
(MACRA) is composed of 11 members appointed
by the Comptroller General. If sign language interpretation or other
ACTION: Notice of public meetings. reasonable accommodation for a
II. Agenda disability is needed, please contact
SUMMARY: This notice announces the At the December 18–20, 2017 Angela Tejeda, no later than December
next meeting of the Physician-Focused meeting, the Committee will hear 4, 2017. Please submit your requests by
Payment Model Technical Advisory presentations on PFPMs that are ready email to Angela.Tejeda@hhs.gov or by
Committee (hereafter referred to as ‘‘the for Committee deliberation. The calling 202–401–8297.
Committee’’) which will be held in presentations will be followed by public
comment and Committee deliberation. If V. Copies of the PTAC Charter and
Washington, DC. This meeting will
the Committee completes deliberations, Meeting Material
include voting and deliberations on
proposals for physician-focused voting will occur on recommendations The Secretary’s Charter for the
payment models (PFPMs) submitted by to the Secretary of Health and Human Physician-Focused Payment Model
members of the public. All meetings are Services. There will be time allocated
Technical Advisory Committee is
open to the public. for public comment on agenda items.
available on the ASPE Web site at
Documents will be posted on the
DATES: The PTAC meeting will occur on https://aspe.hhs.gov/charter-physician-
Committee Web site and distributed on
the following dates: the Committee listserv prior to the focused-payment-model-technical-
• Monday–Wednesday, December public meeting. The agenda is subject to advisory-committee.
18–20, 2017, from 9:00 a.m. to 5:00 p.m. change. If the agenda does change, we Additional material for this meeting
ET. will inform registrants and update our can be found on the PTAC Web site. For
Please note that times are subject to Web site to reflect any changes. updates and announcements, please use
change. If the times change, registrants III. Meeting Attendance the link to subscribe to the PTAC email
will be notified directly via email. listserv.
The meeting is open to the public.
ADDRESSES: The December 18–20, 2017 The public may also attend via Dated: September 12, 2017.
meeting will be held at the Hubert H. conference call or view the meeting via John R. Graham,
Humphrey Building, 200 Independence livestream at www.hhs.gov/live. The Acting Assistant Secretary for Planning and
Avenue SW., Washington, DC 20201. conference call dial-in information will Evaluation.
FOR FURTHER INFORMATION CONTACT: Ann be sent to registrants prior to the [FR Doc. 2017–24719 Filed 11–14–17; 8:45 am]
sradovich on DSK3GMQ082PROD with NOTICES
Page, Designated Federal Official, at the meeting. BILLING CODE 4150–05–P
Office of Health Policy, Assistant Meeting Registration
Secretary for Planning and Evaluation,
The public may attend the meetings
U.S. Department of Health and Human
in-person or participate by phone via
Services, 200 Independence Ave. SW.,
audio teleconference. Space is limited
Washington, DC 20201, (202) 690–6870.
and registration is preferred in order to
SUPPLEMENTARY INFORMATION: attend in-person or by phone.
VerDate Sep<11>2014 19:58 Nov 14, 2017 Jkt 244001 PO 00000 Frm 00061 Fmt 4703 Sfmt 9990 E:\FR\FM\15NON1.SGM 15NON1](https://thefederalregister.org/doc/82_FR_53146/page/7.svg)
Document Created: 2018-10-25 10:37:38
Document Modified: 2018-10-25 10:37:38
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Dates | Submit either electronic or written comments on the collection of information by January 16, 2018. | |
| Contact | Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, [email protected] | |
| FR Citation | 82 FR 52927 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR